Thrombolytics: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
|||
| (34 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
==Thrombolytics | ==Indications== | ||
*[[Thrombolytics for acute ischemic stroke]] | |||
*[[Thrombolytics for pulmonary embolism]] | |||
*[[Thrombolytics for STEMI]] | |||
==[[ | ==Medications== | ||
*[[Alteplase]] (TPA) | |||
*[[Tenecteplase]] (TNKase) | |||
==See Also== | ==See Also== | ||
[[Category: | ==References== | ||
<references/> | |||
[[Category:Cardiology]] | |||
[[Category:Neurology]] | |||
Latest revision as of 06:50, 5 March 2019
Indications
- Thrombolytics for acute ischemic stroke
- Thrombolytics for pulmonary embolism
- Thrombolytics for STEMI
Medications
- Alteplase (TPA)
- Tenecteplase (TNKase)